Syntof-5 contains Tofacitinib (5 mg) an oral Janus kinase (JAK) inhibitor used to treat moderate to severe rheumatoid arthritis psoriatic arthritis and ulcerative colitis. Tofacitinib works by inhibiting specific enzymes involved in the inflammatory process thereby reducing pain swelling and joint damage. This medication is particularly beneficial for patients who have not responded well to traditional disease-modifying antirheumatic drugs (DMARDs). Syntof-5 provides an effective option for managing chronic inflammatory conditions improving patients’ quality of life.
Reviews
There are no reviews yet.